FNDC5 and breast neoplasm: Our novel findings indicate a possible involvement of FNDC5/irisin in breast tumorigenesis, even from very early stages of development of benign growths, as well as in processes of cancer progression, thereby pointing toward its use as a potential diagnostic and prognostic marker for breast neoplasms; this, however, needs to be confirmed in future prospective studies.